Author:
Schmidt-Erfurth Ursula,Lang Gabriele E.,Holz Frank G.,Schlingemann Reinier O.,Lanzetta Paolo,Massin Pascale,Gerstner Ortrud,Bouazza Abdelkader Si,Shen Haige,Osborne Aaron,Mitchell Paul
Reference19 articles.
1. Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies;Ciulla;Diabetes Care,2003
2. Fu AD, Yang SS, McDonald HR. The clinical management of diabetic retinopathy. Adv Stud Ophthalmol. October 2004:18–29. Available at: http://www.jhasio.com/template.cfm?TEMPLATE=include_programinfo.cfm&ID=4&ZoneID=10&TYPE=text. Accessed November 24, 2013.
3. Laser management of diabetic retinopathy;Dowler;J R Soc Med,2003
4. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration;Ferrara;Retina,2006
5. Lucentis. Summary of product characteristics. Section 4.1 Therapeutic indications. 2013. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000715/WC500043546.pdf. Accessed November 24, 2013.
Cited by
278 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献